YM

Yogesh Mehra

Active Director Director DIN 09501524
DIN 09501524 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Yogesh Mehra

Data last updated:

Yogesh Mehra is a Director at Epika Biotech Private Limited (since 2022). The company operates in Pharma. Epika Biotech Private Limited reported revenue of ₹1.08 Cr (FY 2024).

DIN 09501524
Primary Designation Director
Industry Pharma
First Appointment 03 Mar 2022
Oldest Company Age 4 yrs
Largest company Epika Biotech Private Limited · ₹1.08 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epika Biotech Private Limited U51909PN2022PTC209047
Director03 Mar 20222022₹1.08 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Epika Biotech Private Limited
Premium access

Shareholding and investment profile for Yogesh Mehra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Mehra

Yogesh Mehra currently holds 1 directorship: Epika Biotech Private Limited (Director, since 03 Mar 2022, revenue ₹1.08 Cr (FY 2024)).

Yogesh Mehra was first appointed on 03 Mar 2022 as Director at Epika Biotech Private Limited.

The current boards of Yogesh Mehra's companies include Harpreet Singh (Epika Biotech Private Limited), Kuldeep Singh (Epika Biotech Private Limited), Mani Mahajan (Epika Biotech Private Limited), Pankaj Julka (Epika Biotech Private Limited), Pardeep Kumar (Epika Biotech Private Limited), Sanjeev Kumar Arora (Epika Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available